Replies to post #15594 on AEterna Zentaris Inc. (AEZS)

[alexander77]

I really do think that AEZS will be worth ++$20/share if the P3 results are positive. It will happen between the release of the results and the final FDA decision. This is the Adam Feuerstein biotech oncology rule.